Photosensitizer loaded nano-graphene for multimodality imaging guided tumor photodynamic therapy

Theranostics

Volumn 4, Issue 3, 2014, Pages 229-239

  Rong, Pengfei ^a,b   Yang, Kai ^b,c   Srivastan, Avinash ^b   Kiesewetter, Dale O ^b   Yue, Xuyi ^b,d   Wang, Fu ^b   Nie, Liming ^b,d   Bhirde, Ashwinkumar ^b   Wang, Zhe ^b   Liu, Zhuang ^c   Niu, Gang ^b   Wang, Wei ^a   Chen, Xiaoyuan ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^c SOOCHOW UNIVERSITY   (China)

^d XIAMEN UNIVERSITY   (China)

Author keywords

Graphene oxide; HPPH; Optical imaging; Photodynamic therapy; Positron emission tomography

Indexed keywords

GRAPHENE OXIDE; HPPH; OPTICAL IMAGING.; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; CHLOROPHYLL; COPPER RADIOISOTOPES; GRAPHITE; MICE; MICROSCOPY, FLUORESCENCE; MULTIMODAL IMAGING; NANOPARTICLES; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; POLYETHYLENE GLYCOLS; POSITRON-EMISSION TOMOGRAPHY;

EID: 84893588337     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.8070     Document Type: Article

References (33)

1. Josefsen LB, Boyle RW. Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics. Theranostics. 2012; 2: 916-66. doi:10.7150/thno.4571.
2. Dolmans D, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003; 3: 380-7.
3. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin. 2011; 61: 250-81. doi:10.3322/caac.20114.
4. Vrouenraets MB, Visser GW, Stigter M, Oppelaar H, Snow GB, van Dongen GA. Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy. Cancer Res. 2001; 61: 1970-5.
5. Zheng G, Graham A, Shibata M, Missert JR, OseroffAR, Dougherty TJ, et al. Synthesis of beta-galactose-conjugated chlorins derived by enyne metathesis as galectin-specific photosensitizers for photodynamic therapy. J Org Chem. 2001; 66: 8709-16.
6. Vrouenraets MB, Visser GW, Stigter M, Oppelaar H, Snow GB, van Dongen GA. Comparison of aluminium (III) phthalocyanine tetrasulfonate- and meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro. Int J Cancer. 2002; 98: 793-8.
7. Zheng X, Pandey RK. Porphyrin-carbohydrate conjugates: impact of carbohydrate moieties in photodynamic therapy (PDT). Anticancer Agents Med Chem. 2008; 8: 241-68.
8. Mitsunaga M, Ogawa M, Kosaka N, Rosenblum LT, Choyke PL, Kobayashi H. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med. 2011; 17: 1685-91. doi:10.1038/nm.2554.
9. Wang S, Fan W, Kim G, Hah HJ, Lee YE, Kopelman R, et al. Novel methods to incorporate photosensitizers into nanocarriers for cancer treatment by photodynamic therapy. Lasers Surg Med. 2011; 43: 686-95. doi:10.1002/lsm.21113.
10. Gupta A, Wang S, Pera P, Rao KV, Patel N, Ohulchanskyy TY, et al. Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles. Nanomedicine (Lond). 2012; 8: 941-50. doi:10.1016/j.nano.2011.11.011.
11. Samia AC, Chen X, Burda C. Semiconductor quantum dots for photodynamic therapy. J Am Chem Soc. 2003; 125: 15736-7. doi:10.1021/ja0386905.
12. Samia AC, Dayal S, Burda C. Quantum dot-based energy transfer: perspectives and potential for applications in photodynamic therapy. Photochem Photobiol. 2006; 82: 617-25. doi:10.1562/2005-05-11-IR-525.
13. Cheng Y, A CS, Meyers JD, Panagopoulos I, Fei B, Burda C. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. J Am Chem Soc. 2008; 130: 10643-7. doi:10.1021/ja801631c.
14. Peng J, Zhao L, Zhu X, Sun Y, Feng W, Gao Y, et al. Hollow silica nanoparticles loaded with hydrophobic phthalocyanine for near-infrared photodynamic and photothermal combination therapy. Biomaterials. 2013; 34: 7905-12.
15. Lin J, Wang S, Huang P, Wang Z, Chen S, Niu G, et al. Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal/photodynamic therapy. ACS Nano. 2013; 7: 5320-9. doi:10.1021/nn4011686.
16. Lovell JF, Jin CS, Huynh E, Jin H, Kim C, Rubinstein JL, et al. Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat Mater. 2011; 10: 324-32. doi:10.1038/nmat2986.
17. Tian B, Wang C, Zhang S, Feng L, Liu Z. Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. ACS Nano. 2011; 5: 7000-9.
18. Huang P, Xu C, Lin J, Wang C, Wang X, Zhang C, et al. Folic acid-conjugated graphene oxide loaded with photosensitizers for targeting photodynamic therapy. Theranostics. 2011; 1: 240-50.
19. Ethirajan M, Chen YH, Joshi P, Pandey RK. The role of porphyrin chemistry in tumor imaging and photodynamic therapy. Chem Soc Rev. 2011; 40: 340-62.
20. Srivatsan A, Ethirajan M, Pandey SK, Dubey S, Zheng X, Liu TH, et al. Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy. Mol Pharm. 2011; 8: 1186-97.
21. Bellnier DA, Greco WR, Nava H, Loewen GM, OseroffAR, Dougherty TJ. Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy. Cancer Chemother Pharmacol. 2006; 57: 40-5. doi:10.1007/s00280-005-0015-6.
22. Bitounis D, Ali-Boucetta H, Hong BH, Min D-H, Kostarelos K. Prospects and Challenges of Graphene in Biomedical Applications. Adv Mater. 2013; 25: 2258-68: DOI: 10.1002/adma.201203700.
23. Feng LZ, Liu ZA. Graphene in biomedicine: opportunities and challenges. Nanomedicine. 2011; 6: 317-24.
24. Feng L, Zhang S, Liu Z. Graphene based gene transfection. Nanoscale. 2011; 3: 1252-7.
25. Yang X, Wang Y, Huang X, Ma Y, Huang Y, Yang R, et al. Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity. J Mater Chem. 2011; 21: 3448-54.
26. Ma X, Tao H, Yang K, Feng L, Cheng L, Shi X, et al. A functionalized graphene oxide-iron oxide nanocomposite for magnetically targeted drug delivery, photothermal therapy, and magnetic resonance imaging. Nano Res. 2012; 5: 199-212.
27. Zhang SA, Yang K, Feng LZ, Liu Z. In vitro and in vivo behaviors of dextran functionalized graphene. Carbon. 2011; 49: 4040-9.
28. Yang K, Zhang S, Zhang G, Sun X, Lee S-T, Liu Z. Graphene in Mice: Ultra-high in vivo Tumor Uptake and Photothermal Therapy. Nano Lett. 2010; 10: 3318-23.
29. Yang K, Feng L, Shi X, Liu Z. Nano-graphene in biomedicine: theranostic applications. Chem Soc Rev. 2013; 42: 530-47.
30. Shi S, Yang K, Hong H, Valdovinos HF, Nayak TR, Zhang Y, et al. Tumor vasculature targeting and imaging in living mice with reduced graphene oxide. Biomaterials. 2013; 34: 3002-9.
31. Shi X, Gong H, Li Y, Wang C, Cheng L, Liu Z. Graphene-based magnetic plasmonic nanocomposite for dual bioimaging and photothermal therapy. Biomaterials. 2013; 34: 4786-93.
32. Shen H, Zhang L, Liu M, Zhang Z. Biomedical applications of graphene. Theranostics. 2012; 2: 283-94. doi:10.7150/thno.3642.
33. Zhang L, Xia J, Zhao Q, Liu L, Zhang Z. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer Drugs. Small. 2010; 6: 537-44.